New Delhi, 1 Nov 2025: In a bid to fast-track approvals for import licenses and decisions related to serious adverse events (SAE), the Central Drugs Standard Control Organisation (CDSCO) has delegated ...
Mumbai, 29 Oct 2025: The Materiovigilance Programme of India (MvPI), under the aegis of the Indian Pharmacopoeia Commission (IPC), has received and reviewed 47,614 medical device associated adverse ...
New Delhi, 20 Oct 2025: In a bid to tighten regulatory control over alcohol content in cough syrups and tinctures, the Centre has released draft rules to bring certain categories of oral formulations ...
New Delhi/Mumbai, 23 Oct 2025: Eli Lilly and Company (India) Pvt. Ltd. (Lilly), and Cipla Limited and hereafter referred to as "Cipla") today announced an agreement to distribute and promote ...
New Delhi, 12 Aug 2025: A Delhi court on Monday refused to grant anticipatory bail to businessman Vicky Ramancha, the prime accused in an alleged US$18.8 million international scam involving ...
The Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been communicated to the Central Drugs Standard ...
Fake Drug Bust in Agra: Pharma Reps Go Undercover, Lead to Raids on Three Medical Stores (09-11-2025) ...
UBC-developed enzymes successfully converted a kidney to universal type O for transplant (23-10-2025) ...
NABP's Pulse Platform Hits Milestone: Now Operational in 30+ States to Combat Falsified Medicines in U.S. Pharmacy Supply Chain (05-11-2025) ...
Fake Drug Bust in Agra: Pharma Reps Go Undercover, Lead to Raids on Three Medical Stores (09-11-2025) ...
UP FSDA seizes illegal codeine syrups worth lakhs in statewide crackdown (05-11-2025) ...
Eli Lilly's Mounjaro Emerges as India's Top-Selling Drug by Value in October, Surpassing Long-Time Leader Augmentin (07-11-2025) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback